PepGen Inc. (PEPG) vs Neuronetics, Inc. (STIM)
A side-by-side comparison of PepGen Inc. and Neuronetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PEPG
PepGen Inc.
$2.30HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT
STIM
Neuronetics, Inc.
$2.23HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT
Total return — PEPG vs STIM
growth of $100 · dividends reinvested · last 4yPEPG -81.7% (-34.6%/yr)STIM -13.7% (-3.6%/yr)STIM compounded faster over this window
PEPG STIM
PEPG vs STIM: by the numbers
- •PEPG is the larger company ($159M vs $155M market cap).
- •Both run net losses; PEPG's is the smaller (0.00% vs -19.62% net margin).
Metrics side by side
Valuation
| Metric | PEPG | STIM |
|---|---|---|
| P/S ratio | N/A | 1.00 |
| P/B ratio | 1.33 | 8.70 |
Profitability
| Metric | PEPG | STIM |
|---|---|---|
| Gross margin | 0.00% | 49.12% |
| Operating margin | 0.00% | -14.74% |
| Net margin | 0.00% | -19.62% |
| ROE | -60.19% | -170.49% |
| ROIC | -57.59% | -22.15% |
Growth (annualized)
| Metric | PEPG | STIM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 23.26% |
| Total return CAGR (5Y) | N/A | -19.46% |
Go deeper
Dig into the metrics
PepGen ROENeuronetics ROEPepGen operating marginNeuronetics operating marginPepGen revenue growthNeuronetics revenue growthPepGen free cash flowNeuronetics free cash flow
PepGen & Neuronetics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.